参考文献/References:
[1]Blum JL,Flynn PJ,Yothers G,et al.?Anthracyclines in early breast cancer:the ABC trials-USOR 06-090,NSABP B-46-I/USOR 07132,and NSABP B-49 (NRG Oncology)[J].?J Clin Oncol,2017,35(23):2647-2655.
[2]Nicolazzi MA,Carnicelli A,Fuorlo M,et al. Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer[J]. Eur Rev Med Pharmacol Sci,2018,22(7):2175-2185.
[3]Cappetta D,de Angelis A,Sapio L,et al. Oxidative stress and cellular response to doxorubicin:a common factor in the complex milieu of anthracycline cardiotoxicity[J]. Oxid Med Cell Longev,2017,2017:1521020.
[4]Loar RW,Noel CV,Tunuguntla H,et al. State of the art review:chemotherapy-induced cardiotoxicity in children[J]. Congenit Heart Dis,2018,13(1):5-15.
[5]Sim?nek T,Stérba M,Popelová O,et al. Anthracycline-induced cardiotoxicity:overview of studies examining the roles of oxidative stress and free cellular iron[J]. Pharmacol Rep,2009,61(1):154-171.
[6]Xu X,Persson HL,Richardson DR. Molecular pharmacology of the interaction of anthracyclines with iron[J]. Mol Pharmacol,2005,68(2):261-271.
[7]Barry E,Alvarez JA,Scully RE,et al. Anthracycline-induced cardiotoxicity:course,pathophysiology,prevention and management[J]. Expert Opin Pharmacother,2007,8(8):1039-1058.
[8]Leong SL,Chaiyakunapruk N,Lee SW. Candidate gene association studies of anthracycline-induced cardiotoxicity:a systematic review and meta-analysis[J]. Sci Rep,2017,7(1):39.
[9]赵亚娜,李倩晓,施育平. miRNA与心肌细胞凋亡研究进展[J]. 中国组织化学与细胞化学杂志,2020,29(2):179-182.
[10]Zhu JN,Fu YH,Hu ZQ,et al. Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity[J]. Sci Rep,2017,7(1):11879.
[11]Terentyev D,Belevych AE,Terentyeva R,et al. miR-21 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKⅡ-dependent hyperphosphorylation of RyR2[J]. Circ Res,2009,104(4):514-521.
[12]杨宝峰,张勇,单宏丽,等. 微小RNA——心血管疾病药物研发新靶点[C].中国药学会.2013年中国药学大会暨第十三届中国药师周论文集.南宁:2013:14-15.
[13]Mazza T,Gioffreda D,Fontana A,et al. Clinical significance of circulating miR-1273g-3p and mir-122-5p in pancreatic cancer[J]. Front Oncol,2020,10:44.
[14]Guo H,Zeng X,Li H,et al. Plasma miR-1273g-3p acts as a potentiall biomarker for early Breast Ductal Cancer diagnosis[J]. An Acad Bras Cienc,2020,92(1):e20181203.
[15]Caboux E,Paciencia M,Durand G,et al. Impact of delay to cryopreservation on RNA integrity and genome-wide expression profiles in resected tumor samples[J]. PLoS One,2013,8(11):e79826.
[16]Li Z,Stonehuerner J,Devlin RB,et al. Discrimination of vanadium from zinc using gene profiling in human bronchial epithelial cells[J]. Environ Health Perspect,2005,113(12):1747-1754.
[17]Alonso-Herranz L,Sahún-Espa?ol ?,Paredes A,et al. Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP/TGFβ1 after myocardial infarction[J]. Elife,2020,9:e57920.
[18]Lin H,Ruan GY,Sun XQ,et al. Effects of RNAi-induced Skp2 inhibition on cell cycle,apoptosis and proliferation of endometrial carcinoma cells[J]. Exp Ther Med,2019,17(5):3441-3450.
[19]Li C,Du L,Ren Y,et al. SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination[J]. J Exp Clin Cancer Res,2019,38(1):76.
[20]高媛,郭敏,胡晓玲,等. S期激酶相关蛋白2对食管鳞癌细胞增殖、迁移的影响及其作用机制[J]. 中国生物制品学杂志,2021,34(2):146-151.
[21]Liu Y,Wang Y,Cheng C,et al. A relationship between p27(kip1) and Skp2 after adult brain injury:implications for glial proliferation[J]. J Neurotrauma,2010,27(2):361-371.
[22]Tamamori-Adachi M,Takagi H,Hashimoto K,et al. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase[J]. Cardiovasc Res,2008,80(2):181-190.
[23]Wu H,Wang Y,Wang X,et al. MicroRNA-365 accelerates cardiac hypertrophy by inhibiting autophagy via the modulation of Skp2 expression[J]. Biochem Biophys Res Commun,2017,484(2):304-310.
[24]Yang L,Wang S,Ma J,et al. CD74 knockout attenuates alcohol intake-induced cardiac dysfunction through AMPK-Skp2-mediated regulation of autophagy[J]. Biochim Biophys Acta Mol Basis Dis,2019,1865(9):2368-2378.
相似文献/References:
[1]董新江 尚茹茹 刘晓红.乳腺癌放化疗引起心脏毒性的一级预防进展[J].心血管病学进展,2020,(1):78.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.021]
DONG Xinjiang,SHANG Ruru,?LIU Xiaohong.Primary Prevention of Cardiotoxicity Caused by Radiotherapy and Chemotherapy for Breast Cancer[J].Advances in Cardiovascular Diseases,2020,(3):78.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.021]
[2]布热比古力·阿布力米提 付真彦.乳腺癌药物治疗与心肌损伤[J].心血管病学进展,2020,(8):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
Burebiguli·abulimitiFU Zhenyan.Drug Therapy of Breast Cancer and Assosiated Myocardial Damage[J].Advances in Cardiovascular Diseases,2020,(3):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
[3]臧童童 沈雳.基因多态性与心力衰竭发生和发展的研究进展[J].心血管病学进展,2021,(6):516.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.010]
ZANG TongtongSHEN Li.The Relationship Between Gene Polymorphism and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):516.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.010]
[4]戴秋月 郎吉萍 吕萍 潘杭雨 郭志刚.他汀类药物抗乳腺癌作用的研究进展[J].心血管病学进展,2021,(9):776.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
DAI Qiuyue,LANG Jiping,LYU Ping,et al.Effect of Statins Against Breast Cancer[J].Advances in Cardiovascular Diseases,2021,(3):776.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[5]郭良 黄鹤.恶性肿瘤相关心房颤动发病机制的研究进展[J].心血管病学进展,2022,(10):870.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.002]
GUO LiangHUANG He.Pathogenesis of Malignant Tumor-Related Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(3):870.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.002]
[6]杨仙 陈芸霖 殷跃辉 易鑫 杨敏 崔犇.女性乳腺癌相关性心房颤动的研究现状[J].心血管病学进展,2023,(8):676.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.002]
YANG Xian,CHEN Yunlin,YIN Yuehui,et al.Research Status of Female Breast Cancer Associated Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2023,(3):676.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.002]